Enel SpA (ENL)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 9.222 |
|---|---|
| 52-week range | 8.400 – 10.296 |
| Return, 1 month / 3 months | +4.1% / −6.0% |
| Return, 1 year / 3 years | +13.8% / +93.6% |
| Trend | Below its 200-day average |
| RSI (14) | 60 |
| Volatility (1 year) | 20.8% |
| Worst drawdown (1 year) | -13.9% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Enel is an Italian energy company based in Rome. It generates electricity from a mix of sources including hydroelectric, wind, solar and thermal plants, and it distributes power through its networks. The company also sells electricity and natural gas to households, businesses and public bodies, mainly in Italy and other countries where it operates. Its Enel Green Power arm develops and runs renewable generation, while its grids business maintains the infrastructure that carries power to customers.
Enel SpA trades under the code ENL on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Enel SpA (ENL) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 9.222 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 184 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.8% and over the last three months it fell 6.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.5% | ||
| From 52-week high | -10.3% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.0% | ||
| 6-month return | -4.3% | ||
| 12-month return, skipping the last month | 9.3% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.9% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | +4.1% |
| 3 months | −6.0% |
| 6 months | −4.3% |
| 1 year | +13.8% |
| 3 years | +93.6% |
| 5 years | +77.0% |
Signals
| 50-day / 200-day average | 9.057 / 9.364 |
|---|---|
| Golden / death cross (60 days) | Death, 15 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.141 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jul 2026 | EUR 0.2600 |
| 19 Jan 2026 | EUR 0.2300 |
| 21 Jul 2025 | EUR 0.2550 |
| 20 Jan 2025 | EUR 0.2150 |
| 22 Jul 2024 | EUR 0.2150 |
| 22 Jan 2024 | EUR 0.2150 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.